Literature DB >> 23769159

Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects.

Hyeonseok S Jeong1, Sunho Lee, Sujung Yoon, Jiyoung J Jung, Han Byul Cho, Binna N Kim, Jiyoung Ma, Eun Ko, Jooyeon Jamie Im, Soonhyun Ban, Perry F Renshaw, In Kyoon Lyoo.   

Abstract

BACKGROUND: The presence of morphometric abnormalities of the lateral ventricles, which can reflect focal or diffuse atrophic changes of nearby brain structures, is not well characterized in methamphetamine dependence. The current study was aimed to examine the size and shape alterations of the lateral ventricles in methamphetamine-dependent subjects.
METHODS: High-resolution brain structural images were obtained from 37 methamphetamine-dependent subjects and 25 demographically matched healthy individuals. Using a combined volumetric and surface-based morphometric approach, the structural variability of the lateral ventricles, with respect to extent and location, was examined.
RESULTS: Methamphetamine-dependent subjects had an enlarged right lateral ventricle compared with healthy individuals. Morphometric analysis revealed a region-specific pattern of lateral ventricular expansion associated with methamphetamine dependence, which was mainly distributed in the areas adjacent to the ventral striatum, medial prefrontal cortex, and thalamus.
CONCLUSIONS: Patterns of shape decomposition in the lateral ventricles may have relevance to the structural vulnerability of the prefrontal-ventral striatal-thalamic circuit to methamphetamine-induced neurotoxicity.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Lateral ventricle; Methamphetamine; Neuroimaging; Surface-based morphometry

Mesh:

Substances:

Year:  2013        PMID: 23769159      PMCID: PMC5510466          DOI: 10.1016/j.drugalcdep.2013.05.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  52 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Morphological changes in aging brain structures are differentially affected by time-linked environmental influences despite strong genetic stability.

Authors:  Adolf Pfefferbaum; Edith V Sullivan; Dorit Carmelli
Journal:  Neurobiol Aging       Date:  2004-02       Impact factor: 4.673

3.  Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors.

Authors:  Martin Styner; Jeffrey A Lieberman; Robert K McClure; Daniel R Weinberger; Douglas W Jones; Guido Gerig
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

4.  Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.

Authors:  Owen T Carmichael; Lewis H Kuller; Oscar L Lopez; Paul M Thompson; Rebecca A Dutton; Allen Lu; Sharon E Lee; Jessica Y Lee; Howard J Aizenstein; Carolyn C Meltzer; Yanxi Liu; Arthur W Toga; James T Becker
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jan-Mar       Impact factor: 2.703

5.  Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.

Authors:  Killian A Welch; Andrew C Stanfield; Andrew M McIntosh; Heather C Whalley; Dominic E Job; Thomas W Moorhead; David G C Owens; Stephen M Lawrie; Eve C Johnstone
Journal:  Br J Psychiatry       Date:  2011-09-08       Impact factor: 9.319

6.  Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.

Authors:  J Scheel-Krüger
Journal:  Acta Neurol Scand Suppl       Date:  1986

7.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

8.  Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers.

Authors:  Seog Ju Kim; In Kyoon Lyoo; Jaeuk Hwang; Ain Chung; Young Hoon Sung; Jihyun Kim; Do-Hoon Kwon; Kee Hyun Chang; Perry F Renshaw
Journal:  Int J Neuropsychopharmacol       Date:  2005-06-28       Impact factor: 5.176

9.  Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

Authors:  J F Cubells; S Rayport; G Rajendran; D Sulzer
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

10.  Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex.

Authors:  Christian Gaser; Igor Nenadic; Bradley R Buchsbaum; Erin A Hazlett; Monte S Buchsbaum
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

View more
  3 in total

1.  Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.

Authors:  Marc J Kaufman; Amy C Janes; James I Hudson; Brian P Brennan; Gen Kanayama; Andrew R Kerrigan; J Eric Jensen; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2015-05-07       Impact factor: 4.492

2.  Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.

Authors:  Jie Shi; Cynthia M Stonnington; Paul M Thompson; Kewei Chen; Boris Gutman; Cole Reschke; Leslie C Baxter; Eric M Reiman; Richard J Caselli; Yalin Wang
Journal:  Neuroimage       Date:  2014-10-05       Impact factor: 6.556

Review 3.  Structural imaging for addiction medicine: From neurostructure to neuroplasticity.

Authors:  Gregory G Brown; Joanna Jacobus; Benjamin McKenna
Journal:  Prog Brain Res       Date:  2015-10-27       Impact factor: 2.453

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.